
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.
A commonly prescribed antibiotic and alpha-blockerappear to be ineffective in the treatment of men with moderate to severechronic prostatitis/chronic pelvic pain syndrome of long duration. Bothciprofloxacin and tamsulosin-used primarily in the treatment of UTI andBPH, respectively-offered no significant benefit in the treatment of chronicprostatitis in patients who were heavily pretreated and had long-standingsymptoms, a multicenter study shows.





